ATHXQ — Athersys Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $9.77m
- $5.33m
Brief: Athersys Inc Announces $3.7 Million Registered Direct Offering And Concurrent Private Placement
Brief: Athersys Inc Files For Stock Offering Of Up To 13 Million Shares - SEC Filing
Brief: Athersys Reports Fourth Quarter And Full Year 2022 Financial Results And Business Highlights
Brief: Athersys Announces Successful Type B Meeting With The FDA
Athersys Inc expected to post a loss of 85 cents a share - Earnings Preview
Brief: Athersys Expands Ip Protection With First New Patent For Sifu® Technology
U.S. STOCKS ON THE MOVE-Packaged food makers, energy firms, Thomson Reuters
Athersys up as FDA grants clinical meeting to discuss stroke therapy study
Brief: Athersys Granted Clinical Type B Meeting With FDA For Masters-2 Clinical Trial Protocol Discussion
Brief: Athersys Inc Has Until April 12 To Regain Nasdaq Compliance Under Market Value Standard
Brief: Athersys Provides Multistem Clinical Update
Brief: Athersys Appoints Joseph Nolan To Its Board Of Directors
Brief: Athersys Receives Nasdaq Notification About Not Satisfying Continued Listing Requirement
Brief: Athersys Reports Q3 Financial Results And Provides Business Update
Athersys Inc reports results for the quarter ended in September - Earnings Summary
Athersys Inc expected to post a loss of $1.96 a share - Earnings Preview
Athersys Inc expected to post a loss of $1.96 a share - Earnings Preview
Brief: Athersys Inc Announces Proposed Public Offering
Brief: Athersys Amends Securities Purchase Agreement In Connection With Recent Registered Direct Offering